Worldwide use of factor IX Padua for hemophilia B gene therapy

Mol Ther. 2022 Jul 6;30(7):2394-2396. doi: 10.1016/j.ymthe.2022.06.002. Epub 2022 Jun 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dependovirus / genetics
  • Factor IX / genetics
  • Genetic Therapy
  • Hemophilia B* / genetics
  • Hemophilia B* / therapy
  • Humans

Substances

  • factor IX-Padua
  • Factor IX